Filing search / Incannex Healthcare Limited / "CO2"

10-K

2024 FY

IXHL Incannex Healthcare Limited

30 Sep 24

Annual report

7:30am

metabolic acidosis, signaling to the body that there is excess CO2 in the blood, thus increasing respiration. By combining two agents with mechanisms

S-1/A

IXHL Incannex Healthcare Limited

17 Jul 24

IPO registration (amended)

8:47am

that there is excess CO2 in the blood, thus increasing respiration. By exploiting two mechanisms that both reduce AHI in one pharmaceutical formulation, we

S-1

IXHL Incannex Healthcare Limited

3 Jul 24

IPO registration

6:29am

, and acetazolamide induces modest metabolic acidosis, signaling to the body that there is excess CO2 in the blood, thus increasing respiration

20-F

2022 FY

IXHL Incannex Healthcare Limited

28 Oct 22

Annual report (foreign)

6:31am

, signaling to the body that there is excess CO2 in the blood, thus increasing respiration. By exploiting two mechanisms that both reduce AHI in one

6-K

EX-99.1

d8g5 xd4iy

19 Sep 22

Report of Foreign Private Issuer

9:38pm

20FR12B/A

gz7i1 cdtc1ryypa9

24 Feb 22

Initial registration of securities (foreign private issuers) (amended)

3:42pm

20FR12B/A

6lalci0lkys7g

22 Feb 22

Initial registration of securities (foreign private issuers) (amended)

6:10am

20FR12B

u90p209 8cqtw8qe

24 Jan 22

Initial registration of securities (foreign private issuers)

8:18pm

F-1/A

ohp0x5g5wm1z01 mrm

7 Dec 21

Registration statement (foreign) (amended)

5:21pm

F-1/A

2yqyqddrsa98opw

23 Nov 21

Registration statement (foreign) (amended)

3:28pm

F-1/A

jvofate

3 Nov 21

Registration statement (foreign) (amended)

6:06am

F-1/A

p8jaq

28 Sep 21

Registration statement (foreign) (amended)

6:06am

F-1

l9mhvl

17 Aug 21

Registration statement (foreign)

4:39pm